Are national quality standards for traditional Chinese herbal medicine sufficient? Current governmental regulations for traditional Chinese herbal medicine in certain Western countries and China as the Eastern origin country.

[1]  J. Barnes.  Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part II: Efficacy and safety. , 2003, British journal of clinical pharmacology.

[2]  Joanne Barnes,et al.  Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part I. Regulation and quality. , 2003, British journal of clinical pharmacology.

[3]  S. Kirchhoff,et al.  In defence of traditional Chinese herbal medicine , 2003, Anaesthesia.

[4]  G. Coetzee.  Flow through disposable alternatives to the laryngeal mask , 2003, Anaesthesia.

[5]  D. Briggs.  The regulation of herbal medicines in Australia. , 2002, Toxicology.

[6]  D. Eisenberg,et al.  Credentialing Complementary and Alternative Medical Providers , 2002, Annals of Internal Medicine.

[7]  S. Willich,et al.  Availability of Research Results on Traditional Chinese Pharmacotherapy , 2002, Complementary Medicine Research.

[8]  Jun Ren,et al.  Current status and future direction of Chinese herbal medicine. , 2002, Trends in pharmacological sciences.

[9]  Anne W. Taylor,et al.  The escalating cost and prevalence of alternative medicine. , 2002, Preventive medicine.

[10]  K. Agarwal,et al.  Hepatitis associated with Chinese herbs. , 2002, European journal of gastroenterology & hepatology.

[11]  A. Bensoussan,et al.  Regulation of complementary medicine practitioners in Australia: Chinese medicine as a case example. , 2002, Complementary Therapies in Medicine.

[12]  L. Walker,et al.  UK: the current state of regulation of complementary and alternative medicine. , 2002, Complementary therapies in medicine.

[13]  I. Whyte,et al.  Development of a Chinese Herbal Medicine Toxicology Database* , 2002, Journal of toxicology. Clinical toxicology.

[14]  P. Vereerstraeten,et al.  Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi) , 2000, The New England journal of medicine.

[15]  K. Linde,et al.  Liver enzyme elevations in patients treated with traditional Chinese medicine. , 1999, JAMA.

[16]  W. Weidenhammer,et al.  Beobachtungsstudien im Rahmen eines naturheilkundlichen Klinikverbunds , 1998, Complementary Medicine Research.

[17]  K. Linde,et al.  Beobachtungsstudien im Rahmen eines naturheilkundlichen Klinikverbunds , 1998, Complementary Medicine Research.

[18]  Michael H. Cohen.  Complementary and Alternative Medicine: Legal Boundaries and Regulatory Perspectives , 1998 .

[19]  J. Harborne.  Chinese drug monographs and analysis , 1997 .

[20]  R. Chalmers,et al.  Reversible dilated cardiomyopathy following treatment of atopic eczema with Chinese herbal medicine , 1997, The British journal of dermatology.

[21]  F. Friedl.  Dokumentation von Erfahrungsmaterial der Chinesischen Arzneitherapie , 1995 .

[22]  J. Hummelsberger,et al.  Centrum für Therapiesicherheit in der Traditionellen Chinesischen Arzneitherapie (CTCA) gegründet , 2003 .

[23]  T. Baker,et al.  Traditional Chinese medicine in contemporary China. , 2002, Maryland medicine : MM : a publication of MEDCHI, the Maryland State Medical Society.

[24]  G. Lewith,et al.  Attitudes to traditional Chinese medicine amongst Western trained doctors in the People's Republic of China. , 2001, Social science & medicine.

[25]  P. Pachaly.  Chinese Drug Monographs and Analysis Vol. 1, 1–4 von H. Wagner, R. Bauer, X. Peigen, C. Jianming und A. Nenninger bzw. F. Offermann Verlag für Ganzheitliche Medizin Dr. E. Wühr, D‐93444 Kötzting je Monographie DM 39,‐, ISSN 1430‐8290 , 1997 .

[26]  S. Myers,et al.  Towards a safer choice: the practice of traditional Chinese medicine in Australia , 1996 .